- Correction
- Open access
- Published:
Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial
Annals of Intensive Care volume 13, Article number: 95 (2023)
Correction: Annals of Intensive Care (2023) 13:75 https://doi.org/10.1186/s13613-023-01168-z
In the original version of this article [1], the given and family names of the authors were swapped as Chevret Sylvie, Bouadma Lila, Dupuis Claire, Burdet Charles and Timsit Jean‑Francois. The corrected author names should read as Sylvie Chevret, Lila Bouadma, Claire Dupuis, Charles Burdet and Jean‑Francois Timsit. The original article has been corrected.
Reference
Chevret S, Bouadma L, Dupuis C, Burdet C, Timsit J-F, the COVIDICUS RCT group. Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial. Ann Intensive Care. 2023;13:75. https://doi.org/10.1186/s13613-023-01168-z
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chevret, S., Bouadma, L., Dupuis, C. et al. Correction: Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial. Ann. Intensive Care 13, 95 (2023). https://doi.org/10.1186/s13613-023-01194-x
Published:
DOI: https://doi.org/10.1186/s13613-023-01194-x